However, tumor cells could overexpress the anti-apoptotic gene product (bcl-2) (89) or not express Fas and Fas-related signal transduction molecules to resist the apoptosis mediated by the Fas/FasL pathway and avoid the killing action of activated CTL. The gene discussed is FASLG; the disease is neoplasm.